Race, Natriuretic Peptides and Physiological Perturbations

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

April 30, 2024

Conditions
HealthyPre Hypertension
Interventions
OTHER

Exercise capacity VO2 max determination

Each participant's maximal oxygen capacity will be determined using a modified Bruce treadmill protocol.

DIETARY_SUPPLEMENT

Standardized meals

Participants will consume the standardized study diet for 3 days provided by the clinical research unit's metabolic kitchen (at UAB).

OTHER

Exercise challenge

Each participant will walk at 70 % of his/her VO2max for 20 minutes on treadmill.

DRUG

Metoprolol Succinate ER

Each participant will receive metoprolol succinate starting at 50mg/day, titrated bi-weekly up to 200 mg/day for total duration of 6 weeks.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT03070184 - Race, Natriuretic Peptides and Physiological Perturbations | Biotech Hunter | Biotech Hunter